Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 985 to 987 of 987 entries
Sorted by: Best Match Show Resources per page
A first-in-human study of BLZ-100 (tozuleristide) demonstrates tolerability and safety in skin cancer patients.

Contemporary clinical trials communications

Yamada M, Miller DM, Lowe M, Rowe C, Wood D, Soyer HP, Byrnes-Blake K, Parrish-Novak J, Ishak L, Olson JM, Brandt G, Griffin P, Spelman L, Prow TW.
PMID: 34401600
Contemp Clin Trials Commun. 2021 Aug 04;23:100830. doi: 10.1016/j.conctc.2021.100830. eCollection 2021 Sep.

BLZ-100 (tozuleristide) is an intraoperative fluorescent imaging agent that selectively detects malignant tissue and can be used in real time to guide tumor resection. The purpose of this study was to assess the safety, tolerability, and pharmacokinetics of BLZ-100...

Cite
Yamada M, Miller DM, Lowe M, et al. A first-in-human study of BLZ-100 (tozuleristide) demonstrates tolerability and safety in skin cancer patients. Contemp Clin Trials Commun. 2021;23:100830doi: 10.1016/j.conctc.2021.100830.
Yamada, M., Miller, D. M., Lowe, M., Rowe, C., Wood, D., Soyer, H. P., Byrnes-Blake, K., Parrish-Novak, J., Ishak, L., Olson, J. M., Brandt, G., Griffin, P., Spelman, L., & Prow, T. W. (2021). A first-in-human study of BLZ-100 (tozuleristide) demonstrates tolerability and safety in skin cancer patients. Contemporary clinical trials communications, 23100830. https://doi.org/10.1016/j.conctc.2021.100830
Yamada, Miko, et al. "A first-in-human study of BLZ-100 (tozuleristide) demonstrates tolerability and safety in skin cancer patients." Contemporary clinical trials communications vol. 23 (2021): 100830. doi: https://doi.org/10.1016/j.conctc.2021.100830
Yamada M, Miller DM, Lowe M, Rowe C, Wood D, Soyer HP, Byrnes-Blake K, Parrish-Novak J, Ishak L, Olson JM, Brandt G, Griffin P, Spelman L, Prow TW. A first-in-human study of BLZ-100 (tozuleristide) demonstrates tolerability and safety in skin cancer patients. Contemp Clin Trials Commun. 2021 Aug 04;23:100830. doi: 10.1016/j.conctc.2021.100830. eCollection 2021 Sep. PMID: 34401600; PMCID: PMC8355837.
Copy Download .nbib Format: NLM
UNS: COLLABORATIVE RESEARCH: Study of Amyloid Protein Oligomerization Using Microchannel Electrophoresis.

[No authors listed]
UIID-NSF: 432

1511562/1511876 Moss/Hestekin The aggregation of amyloid proteins is involved in a wide range of processes including the pathogenesis of numerous diseases (Alzheimer's disease, type 2 diabetes, etc.) as well as in biofouling associated with applications such as food production...

Cite
UNS: COLLABORATIVE RESEARCH: Study of Amyloid Protein Oligomerization Using Microchannel Electrophoresis. ;
(). UNS: COLLABORATIVE RESEARCH: Study of Amyloid Protein Oligomerization Using Microchannel Electrophoresis. .
"UNS: COLLABORATIVE RESEARCH: Study of Amyloid Protein Oligomerization Using Microchannel Electrophoresis." vol. ().
UNS: COLLABORATIVE RESEARCH: Study of Amyloid Protein Oligomerization Using Microchannel Electrophoresis. UIID-NSF: 432.
Copy Download .nbib Format: NLM
UNS: COLLABORATIVE RESEARCH: Study of Amyloid Protein Oligomerization Using Microchannel Electrophoresis.

[No authors listed]
UIID-NSF: 431

1511562/1511876 Moss/Hestekin The aggregation of amyloid proteins is involved in a wide range of processes including the pathogenesis of numerous diseases (Alzheimer's disease, type 2 diabetes, etc.) as well as in biofouling associated with applications such as food production...

Cite
UNS: COLLABORATIVE RESEARCH: Study of Amyloid Protein Oligomerization Using Microchannel Electrophoresis. ;
(). UNS: COLLABORATIVE RESEARCH: Study of Amyloid Protein Oligomerization Using Microchannel Electrophoresis. .
"UNS: COLLABORATIVE RESEARCH: Study of Amyloid Protein Oligomerization Using Microchannel Electrophoresis." vol. ().
UNS: COLLABORATIVE RESEARCH: Study of Amyloid Protein Oligomerization Using Microchannel Electrophoresis. UIID-NSF: 431.
Copy Download .nbib Format: NLM
Showing 985 to 987 of 987 entries